Institute of Cancer and Genomic Sciences Using fundamental research and the power of genomics to develop better therapies in cancer and other complex diseases.
News Birmingham-led team of geneticists decodes the inner workings of the zebrafish genome An international team of geneticists has created a comprehensive database defining the functions and properties of all gene regulatory elements in the zebrafish genome throughout fish development
10 June 2020 First drugs announced in major COVID-19 drugs trial Two UK drugs companies will be the first to partner with the Universities of Birmingham and Oxford as part of a major new UK drugs trial to test potential therapeutics to treat patients hospitalised with COVID-19.
09 June 2020 Birmingham scientists 're-train' immune system to prevent attack of healthy cells in new UK study into autoimmune diseases The body's immune system can be re-wired to prevent it from recognising its own proteins which, when attacked by the body, can cause autoimmune diseases like multiple sclerosis.
05 June 2020 Experts release new guidelines for studies into most effective treatments for HPV-positive throat cancer Heightened caution is needed when considering de-escalation trials for patients with Human papillomavirus (HPV)-positive oropharyngeal cancer (OPC), to ensure minimal harm to patients.
29 May 2020 COVID-19 patients who undergo surgery are at increased risk of postoperative death – global study Patients undergoing surgery after contracting coronavirus are at greatly increased risk of postoperative death, a new global study published in The Lancet reveals.
28 May 2020 COVID-19 mortality in cancer patients is not significantly affected by anti-cancer treatments, study finds A new study led by the Universities of Birmingham and Oxford has found the mortality rate in cancer patients who are assessed or treated in hospital with COVID-19 is not significantly affected by anti-cancer treatments.
21 May 2020 University of Birmingham secures funding for critical UK clinical trial for children diagnosed with rare childhood cancer A team will coordinate the UK arm of a critical European clinical trial which could lead to the development of more effective and kinder treatments for children diagnosed with a rare and aggressive childhood cancer.
15 May 2020 COVID-19 disruption will lead to 28 million surgeries cancelled worldwide Over 28 million elective surgeries across the globe could be cancelled as a result of the COVID-19 pandemic – leading to patients facing a lengthy wait for their health issues to be resolved, a new study reveals.
14 May 2020 Three Birmingham Professors announced as Academy of Medical Sciences Fellows Three professors from the University of Birmingham have been named among the UK's most prominent biomedical and health scientists by the Academy of Medical Sciences in its prestigious list of Fellows.
12 May 2020 Major COVID-19 drugs trial begins in Birmingham A trial which will rapidly test new therapies for patients hospitalised due to COVID-19 is opening in Birmingham this week.
06 May 2020 Sarcoma UK invests £250,000 to understand why sarcoma resists immunotherapy Sarcoma UK: Professor Andrew Beggs hopes to use the DNA of cancer cells to answer a very pressing question – why don't sarcomas respond well to immunotherapy?
09 April 2020 University of Birmingham supporting local NHS to upscale testing for frontline staff Labs at the University of Birmingham have been re-purposed to support the testing of frontline NHS staff in the city from this week.
27 March 2020 UK oncologists launch joint project to track cancer patients with COVID-19 A team of oncologists have joined forces to launch the first cancer coronavirus registry in the world to track how cancer patients who have tested positive for COVID-19 will be impacted.